Patient characteristics
| Patient/sex . | Age, y . | Stage . | Type of protein . | Prior therapies . | Time from diagnosis to 1st transplantation, mo . |
|---|---|---|---|---|---|
| 1. M | 32 | IIIB | IgG/K | 5x ID | 6 |
| 2. M | 58 | IIIA | IgA/L | 4x ID | 8 |
| 3. M | 48 | IIA | IgA/K | 4x MP, 5x ID | 11 |
| 4. M | 63 | IIA | IgG/K | 4x VAD | 13 |
| 5. M | 49 | IIIB | IgG/L | 3x MP, 3x VCAP | 9 |
| 6. M | 44 | IIA | Lambda | 3x VAD, 1x Cyclo | 7 |
| 7. F | 48 | IIIA | IgA/K | 4x ID | 7 |
| 8. M | 53 | IIIA | IgG/L | 3x VCAP, 1x Cyclo | 10 |
| 9. M | 61 | IIA | Kappa | 2x MP, 4x VAD, 1x HD-Cht* | 42 |
| 10. F | 34 | IIIA | IgA/L | 4x ID, 1x CAD | 29 |
| 11. F | 40 | IIA | Kappa | 4x ID | 25 |
| 12. M | 53 | IIIA | IgA/K | 4x VCAP, 1x Cyclo | 6 |
| 13. M | 53 | IIIA | IgG/L | 6x VAD | 21 |
| 14. M | 57 | IIA | IgA/K | 4x VCAP | 8 |
| 15. M | 64 | IIIA | IgG/L | 4x ID | 21 |
| 16. F | 51 | IIIA | IgG/K | 2x VAD, 2x Cyclo | 23 |
| 17. F | 51 | IIIA | IgG/K | 4x ID | 5 |
| Patient/sex . | Age, y . | Stage . | Type of protein . | Prior therapies . | Time from diagnosis to 1st transplantation, mo . |
|---|---|---|---|---|---|
| 1. M | 32 | IIIB | IgG/K | 5x ID | 6 |
| 2. M | 58 | IIIA | IgA/L | 4x ID | 8 |
| 3. M | 48 | IIA | IgA/K | 4x MP, 5x ID | 11 |
| 4. M | 63 | IIA | IgG/K | 4x VAD | 13 |
| 5. M | 49 | IIIB | IgG/L | 3x MP, 3x VCAP | 9 |
| 6. M | 44 | IIA | Lambda | 3x VAD, 1x Cyclo | 7 |
| 7. F | 48 | IIIA | IgA/K | 4x ID | 7 |
| 8. M | 53 | IIIA | IgG/L | 3x VCAP, 1x Cyclo | 10 |
| 9. M | 61 | IIA | Kappa | 2x MP, 4x VAD, 1x HD-Cht* | 42 |
| 10. F | 34 | IIIA | IgA/L | 4x ID, 1x CAD | 29 |
| 11. F | 40 | IIA | Kappa | 4x ID | 25 |
| 12. M | 53 | IIIA | IgA/K | 4x VCAP, 1x Cyclo | 6 |
| 13. M | 53 | IIIA | IgG/L | 6x VAD | 21 |
| 14. M | 57 | IIA | IgA/K | 4x VCAP | 8 |
| 15. M | 64 | IIIA | IgG/L | 4x ID | 21 |
| 16. F | 51 | IIIA | IgG/K | 2x VAD, 2x Cyclo | 23 |
| 17. F | 51 | IIIA | IgG/K | 4x ID | 5 |
ID indicates idarubicin/dexamethasone; MP: melphalan/prednisone; VAD: vincristine, Adriamycin, dexamethasone; VCAP: vincristine, cyclophosphamide, Adriamycin, prednisone; Cyclo, cyclophosphamide; CAD: cyclophosphamide, Adriamycin, and dexamethasone.
High-dose chemotherapy consisting of busulfan 14 mg/kg and cyclophosphamide 120 mg/kg.